Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in
Read MoreThe clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in
Read MorePUNE, India, Sept. 7, 2023 /PRNewswire/ — alveofit® (Roundworks Technologies Private Limited) is thrilled to announce that its groundbreaking product,
Read MoreBOSTON and BANGALORE. India, Aug. 11, 2023 /PRNewswire/ — Zumutor Biologics Inc “Zumutor”, a Boston based biopharmaceutical company focused on
Read MoreNovel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids BENGALURU, India,
Read MoreNEW YORK, June 29, 2023 /PRNewswire/ — Cresilon, Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today
Read MoreTHIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY
Read MoreThis is a joint press release by Koninklijke DSM N.V. (DSM), Firmenich International SA (Firmenich) and Danube AG, to be
Read More— CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells — CK0803 represents the company’s fifth program
Read More— CK0804 represents the company’s fourth program to receive IND Clearance — CK0804 is a partnered program with Incyte HOUSTON,
Read MoreThe latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise. JENA, Germany
Read More